Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis. - Wikidata - awgldk - TriplyDB

Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

http://www.wikidata.org/entity/Q30502919

about

Cytomegalovirus antivirals and development of improved animal models Evaluation of SQ 34,514: pharmacokinetics and efficacy in experimental herpesvirus infections in mice.Guinea pig cytomegalovirus immediate-early transcription.Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.Therapy of idiopathic sudden sensorineural hearing loss: antiviral treatment of experimental herpes simplex virus infection of the inner ear.Do viruses cause inner ear disturbances?

P2860

Q27000998-3443925B-74A6-49D3-BE2C-8D404F83E930 Q36754271-B399474D-FCA6-455B-9031-54818BDE901A Q36803306-98247819-FBF8-43B3-9C6E-F5388E346AF4 Q37357122-348A2034-ACA9-424A-8218-0572137D5C74 Q37453329-BD0B3F5D-1957-4DF7-BBFC-D21E69468338 Q45749352-3856BB29-527A-4D7D-970D-FB9F83DBEB8C Q50084100-DE0788C5-C302-4EA3-9DAA-FFD5889461A9

P2860

Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.

http://www.wikidata.org/entity/Q30502919

description

1988 nî lūn-bûn

@nan

1988 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@ast

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@en

type

label

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@ast

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@en

prefLabel

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@ast

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@en

P1433

Q30502919-A4F94BDA-410C-483A-A9AD-6497F5D233D2

P1476

Q30502919-5AB607F5-F276-4EA8-8FD8-D7D0EDE8BDA9

P2093

Q30502919-26DE1418-6C50-4CB9-82F7-4BFFAC03F622

Q30502919-346E2B3F-6A5C-4FC3-A94B-1A65B3A03D58

Q30502919-3E2AFC80-9B2E-4AC2-9AD0-FAE4ED37C50F

Q30502919-72CB9AF2-1591-4A3B-85D7-2B71F3C0DA31

Q30502919-DD6E9AD4-B206-41E2-A850-B19E3DE95236

Q30502919-E770F6E6-FBDD-4781-811A-2C7A5CD1DDF1

P2860

Q30502919-0793B193-EB02-4D1C-A7D6-089110511D7C

Q30502919-0A30F437-321F-4B23-A400-778E146B6539

Q30502919-15B7E82E-AD8D-40CA-A680-66CE1B9F54A5

Q30502919-245CE252-FF6E-4FB1-8B84-621ACB1244F6

Q30502919-27920A99-F3B5-4076-A5B9-040B127112B1

Q30502919-2DEBC280-8629-4B05-8D25-B3EB7F0BA66C

Q30502919-3DA49A0A-EA63-45FD-865B-D556409B9955

Q30502919-4CB85241-60C7-49CC-B38E-41256AE59FA0

Q30502919-55079423-718D-4B28-9936-562BE5A250C1

Q30502919-5C33EBBB-E285-4BF8-8CD5-F5E5EBA7AF59

P304

Q30502919-B111B8FD-7B4B-45C3-933F-06A12995B7D8

P31

Q30502919-BC7A5FC2-23E2-4F33-B4A0-1A9B384E921C

P356

Q30502919-54726194-5313-4F2E-9732-55729F920C35

P407

Q30502919-DB02097A-E752-4241-9C0E-EB09656E873E

P433

Q30502919-A315632D-F47E-4AF3-956E-FBBAFFA2B493

P478

Q30502919-D012A155-2C0A-415D-B053-77F5F702DE32

P577

Q30502919-540B6761-4D0E-45CA-A176-F7F8D27D26CA

P5875

Q30502919-2A2551D2-F03D-4152-8568-8AA321C6EE25

P698

Q30502919-9454539D-2784-4F57-8DA4-8BBA9CF5934D

P921

Q30502919-316254D4-1DA8-4358-93FE-33AB88005A1A

Q30502919-FD01C4B8-CB07-4997-ADED-9230509F4183

P932

Q30502919-2D714D7F-5762-4485-B266-E0CF8F4A725D

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Ganciclovir prophylaxis for co ...... cytomegalovirus labyrinthitis.

@en

P2093

D D Richman

http://www.w3.org/2001/XMLSchema#string

E J Silva

http://www.w3.org/2001/XMLSchema#string

J P Harris

http://www.w3.org/2001/XMLSchema#string

J W Ochi

http://www.w3.org/2001/XMLSchema#string

N K Woolf

http://www.w3.org/2001/XMLSchema#string

P A Sharp

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Effects of the nucleoside analog 2'-nor-2'-deoxyguanosine on human cytomegalovirus replication

Comparison of guinea pig cytomegalovirus and guinea pig herpes-like virus: pathogenesis and persistence in experimentally infected animals.

Inhibition of murine cytomegalovirus lung infection and interstitial pneumonitis by acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro.

Autopsy pathology in the acquired immune deficiency syndrome.

Psoralen inactivation of influenza and herpes simplex viruses and of virus-infected cells.

Congenital cytomegalovirus.

Immunoenzymatic staining of viral and chlamydial antigens in cell culture.

Congenital cytomegalovirus infection in an urban Canadian community.

P304

865-872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.32.6.865

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

1988-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20313331

http://www.w3.org/2001/XMLSchema#string

P698

2843084

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

Cytomegalovirus

P932

172297

http://www.w3.org/2001/XMLSchema#string